Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis.
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansThe role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagyImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisPalmitate impairs angiogenesis via suppression of cathepsin activityLG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.Coagulation and autoimmunity in scleroderma interstitial lung disease.Apoptosis in capillary endothelial cells in ageing skeletal muscleApoptosis modulation as a promising target for treatment of systemic sclerosis.Caspase activation regulates the extracellular export of autophagic vacuolesThe bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms.Mechanisms and consequences of fibrosis in systemic sclerosis.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengersMechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.Autoimmunity in systemic sclerosis: current concepts.Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expressionVascular disease in scleroderma.Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.The immunology of fibrosis: innate and adaptive responses.Animal model of systemic sclerosis.Autoimmune mechanisms of scleroderma and a role of oxidative stress.Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.The pathogenesis, diagnosis and treatment of Raynaud phenomenon.Vascular changes in bleomycin-induced scleroderma.The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.Additive benefits of chondroitin sulfate and oriented tethered epidermal growth factor for vascular smooth muscle cell survival.Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis.Chondroitin-4-sulfate: a bioactive macromolecule to foster vascular healing around stent-grafts after endovascular aneurysm repair.Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease.Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF.MFG-E8 released by apoptotic endothelial cells triggers anti-inflammatory macrophage reprogramming.Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communicationAn in vitro investigation of herbs traditionally used for kidney and urinary system disorders: potential therapeutic and toxic effects.Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis.Collagen V and vascular injury promote lung architectural changes in systemic sclerosis.Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells.A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells.Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin
P2860
Q21710680-370FF27D-72AB-4889-92CC-1778CFDE0388Q26800258-3C918989-8D1C-4A9B-8B64-056C486FD914Q28084366-CFE64A06-45F2-4DF3-A306-14A0AB4D3B93Q33702034-7D448A63-5883-4CCF-8A54-3ECF824992B8Q34480669-85866E47-12FD-4167-9DE0-B63F49FD7A41Q34770486-0136D13F-B9C1-47A3-B6A0-22E2AE0BCF02Q35093128-5BFA6E4F-94E5-4108-8157-955DCE807180Q35207610-B147FB1A-F898-4778-9B77-1CB85CA60B8CQ36187777-48563BCF-2E2F-42D5-8C8A-31F96ECB6AF0Q36364488-1432E90B-3077-4D84-A854-A6993B49F2E7Q36373575-37AD7164-52E5-473B-88F5-B26F38CF8480Q36577428-7B2FEEA2-D1BF-4E8F-B84B-78308C995E26Q36578668-55136311-1A1E-4F49-A9A1-377A862B84C6Q36667816-9DBBC976-B0BE-4E7E-A491-77748EE5621EQ36821512-2E7D345A-0583-42ED-BB98-9C6A40284397Q37253350-3218D616-527A-4976-8A29-87D1B618ED6EQ37344793-E4762EBC-E30B-4256-8DC9-58C2C932E09BQ37494563-11476528-5E9A-4BE0-830F-C5A55C24CC0EQ37682484-0D3A39C9-7A8D-4B5B-BC45-81F7CB3CF349Q37696569-810E0AF4-72D9-4901-B2DE-A46DC78B2CA5Q37903252-081D8105-58EB-466C-9C1E-1F58DB20465CQ37954366-5EEA6FF6-096A-4403-9705-142993A4ACB0Q38025285-1137B4B7-3141-4599-8AC7-19625312B3E3Q38790174-57C108A3-EBD2-44DF-85CC-49F3C5E77E2CQ38995184-3AC099F1-8C3B-4DAB-B85C-7F13F79908E5Q39029834-667DD568-FD80-4AC9-9DED-9A6724603736Q39956889-E9985F24-C00D-4650-91DD-CBA076B8019EQ40141356-96A1D2EA-C18B-4E64-9E94-5E2DADEA0211Q40659360-1BB76352-B619-4454-953D-680D523A7E24Q41619893-7D7E7FB3-4511-4C71-B12B-895FF39DDF8CQ42141658-25B8D9A4-FAB0-47F8-AE22-29CE773268F7Q42790812-B7E9FB78-CD2D-4C82-9B57-DFF7EB097C20Q46353457-924D6E0F-65DA-480D-8A1D-1F05ED3CD6F7Q48245847-E74E10DF-7ADD-4CA8-8FF1-4EDFDA84BC93Q52599289-D6C1B36C-457F-43F1-BE08-FAE05C6E1ADEQ53338288-CE408004-8A1D-412E-A224-51F2E52E5AB1Q54447739-4F4704E4-77B9-4C72-BD23-58811FC4EFCBQ57486499-82326855-3465-4F03-940D-C26E357C01E9
P2860
Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Novel fibrogenic pathways are ...... siology of systemic sclerosis.
@en
type
label
Novel fibrogenic pathways are ...... siology of systemic sclerosis.
@en
prefLabel
Novel fibrogenic pathways are ...... siology of systemic sclerosis.
@en
P2093
P921
P1476
Novel fibrogenic pathways are ...... siology of systemic sclerosis.
@en
P2093
A Marie-Josée Sasseville
Gabrielle Gagnon
Marc-André Raymond
Marie-Josée Hébert
Monique Bernard
Normand Vigneault
Patrick Laplante
Yves Langelier
Yves Raymond
P304
P356
10.4049/JIMMUNOL.174.9.5740
P407
P577
2005-05-01T00:00:00Z